United States Anti-Doping Agency Reauthorization Act of 2021

United States117th CongressHR-172House of Representatives
Updated: Apr 15, 2021

Summary

United States Anti-Doping Agency Reauthorization Act of 2021 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030. The bill adds requirements that USADA be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports. The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection. The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill texts

Available versions
View official text

3 versions available

All available records shown.

Timeline

Latest companion bill action

S-585: United States Anti-Doping Agency Reauthorization Act of 2021

Introduced in Senate

  1. Considered as unfinished business. (consideration: CR H1781-1782)

    House of Representatives

  2. On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)

    House of Representatives

    View vote
  3. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Senate